Comparison of a 3-day with a 1-day regimen of an extended-release formulation of ciprofloxacin as antimicrobial prophylaxis for patients undergoing transrectal needle biopsy of the prostate

BJU International

Volumn 100, Issue 1, 2007, Pages 51-57

  Schaeffer, Anthony J ^a   Montorsi, Francesco ^b   Scattoni, Vincenzo ^b   Perroncel, Renee ^c   Song, James ^c   Haverstock, Daniel C ^c   Pertel, Peter E ^c  

^a NORTHWESTERN UNIVERSITY   (United States)

^b VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

^c BAYER CORPORATION   (United States)

Author keywords

Antimicrobial prophylaxis; Ciprofloxacin; Extended release; Infection; Prostate biopsy

Indexed keywords

CIPROFLOXACIN; PLACEBO;

ADULT; AGED; ANTIBIOTIC PROPHYLAXIS; ARTICLE; BACTERIAL INFECTION; CLINICAL TRIAL; CONFIDENCE INTERVAL; CONTROLLED CLINICAL TRIAL; CONTROLLED RELEASE FORMULATION; CONTROLLED STUDY; DIABETES MELLITUS; DIZZINESS; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG INDUCED HEADACHE; DRUG SAFETY; DRUG TREATMENT FAILURE; GLUCOSE BLOOD LEVEL; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MICROBIOLOGICAL EXAMINATION; MULTICENTER STUDY; MULTIVARIATE ANALYSIS; NAUSEA; NEEDLE BIOPSY; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROSTATE BIOPSY; PROSTATITIS; RANDOMIZED CONTROLLED TRIAL; RHINOPHARYNGITIS; SIDE EFFECT; SINGLE DRUG DOSE; TRIACYLGLYCEROL LIPASE BLOOD LEVEL;

AGED; ANTI-INFECTIVE AGENTS; BACTERIAL INFECTIONS; BIOPSY, NEEDLE; CIPROFLOXACIN; DELAYED-ACTION PREPARATIONS; DOUBLE-BLIND METHOD; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROSPECTIVE STUDIES; PROSTATE; PROSTATIC NEOPLASMS; TIME FACTORS; TREATMENT OUTCOME;

EID: 34249951354     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/j.1464-410X.2007.06848.x     Document Type: Article

References (23)

1. Raaijmakers R, Kirkels WJ, Roobol MJ, Wildhagen MF, Schröder FH. Complication rates and risk factors of 5802 transrectal ultrasound-guided sextant biopsies of the prostate within a population-based screening program. Urology 2002 60 : 826 30
2. Brullet E, Guevara MC, Campo R et al. Massive rectal bleeding following transrectal ultrasound-guided prostate biopsy. Endoscopy 2000 32 : 792 5
3. Thompson PM, Talbot RW, Packham DA, Dulake C. Transrectal biopsy of the prostate and bacteraemia. Br J Surg 1980 67 : 127 8
4. Webb NR, Woo HH. Antibiotic prophylaxis for prostate biopsy. BJU Int 2002 89 : 824 8
5. No authors listed. Antimicrobial prophylaxis in surgery. Med Lett Drugs Ther 1999 41 : 75 9
6. Davis M, Sofer M, Kim SS, Soloway MS. The procedure of transrectal ultrasound guided biopsy of the prostate: a survey of patient preparation and biopsy technique. J Urol 2002 167 : 566 70
7. Patel HR, Lee F, Arya M, Masood S, Palmer JH, Sheriff MK. A national survey of transrectal ultrasound-guided prostatic biopsies: time for a national guideline. Int J Clin Pract 2003 57 : 773 4
8. Shandera KC, Thibault GP, Deshon GE Jr. Variability in patient preparation for prostate biopsy among American urologists. Urology 1998 52 : 644 6
9. Puig J, Dranell A, Bermúdez P et al. Transrectal ultrasound-guided prostate biopsy: is antibiotic prophylaxis necessary? Eur Radiol 2006 16 : 939 43
10. Thompson PM, Pryor JP, Williams JP et al. The problems of infection after prostatic biopsy: the case for the transperineal approach. Br J Urol 1982 54 : 736 40
11. Taylor HM, Bingham JB. The use of prophylactic antibiotics in ultrasound-guided transrectal prostate biopsy. Clin Radiol 1997 52 : 787 90
12. Janoff DM, Skarecky DW, McLaren CE, Aherling TE. Prostate needle biopsy infection after four or six dose ciprofloxacin. Can J Urol 2000 7 : 1066 9
13. Sabbagh R, McCormack M, Peloquin F et al. A prospective randomized trial of 1-day versus 3-day antibiotic prophylaxis for transrectal ultrasound guided prostate biopsy. Can J Urol 2004 11 : 2216 9
14. Aron M, Rajeev TP, Gupta NP. Antibiotic prophylaxis for transrectal needle biopsy of the prostate: a randomized controlled study. BJU Int 2000 85 : 682 5
15. Tobias-Machado M, Corra TD, De Barros EL, Wroclawski ER. Antibiotic prophylaxis in prostate biopsy. A comparative randomized clinical assay between ciprofloxacin, norfloxacin and chloramphenicol. Int Braz J Urol 2003 29 : 313 9
16. Aus G, Ahlgren G, Bergdahl S, Hugosson J. Infection after transrectal core biopsies of the prostate - risk factors and antibiotic prophylaxis. Br J Urol 1996 77 : 851 5
17. Sieber PR, Rommel FM, Agusta VE, Breslin JA, Huffnagle HW, Harpster LE. Antibiotic prophylaxis in ultrasound guided transrectal prostate biopsy. J Urol 1997 157 : 2199 200
18. Crawford ED, Haynes AL Story MW, Borden TA. Prevention of urinary tract infection and sepsis following transrectal prostatic biopsy. J Urol 1982 127 : 449 51
19. Breslin JA, Turner BI, Faber RB, Rhamy RK. Anaerobic infection as a consequence of transrectal prostatic biopsy. J Urol 1978 120 : 502 3
20. Harris LF, Jackson RT, Breslin JA Alford RH. Anaerobic septicemia after transrectal prostatic biopsy. Arch Intern Med 1978 138 : 393 5
21. Thauvin-Eliopoulos C, Eliopoulos GM. Activity in vitro of the quinolones. In Hooper DC, Rubinstein E, Quinolone Antimicrobial Agents, 3rd edn. Washington, DC : ASM Press, 2003 : 91 111
22. Agresti A. Categorical Data Analysis. New York : John Wiley & Sons, 1990
23. Childs S, Krieger J, Lettieri J, Stass H, Agarwal V. Ciprofloxacin pharmacokinetics (PK) in prostate tissue following a single 1000 mg oral ciprofloxacin extended release tablet (Cipro XR). J Clin Pharmacol 2004 44 : 1203, Abstract 75